What is Siponimod: Uses, Dosage, Side Effects and More

Siponimod is a prescription medication specifically designed to treat secondary progressive multiple sclerosis (SPMS). It belongs to a class of drugs called sphingosine 1-phosphate receptor modulators, which work by keeping certain immune cells from attacking your nervous system. This oral medication can help slow down the progression of disability and reduce the frequency of relapses in people with SPMS.

What is Siponimod?

Siponimod is an immunomodulating drug that helps manage secondary progressive multiple sclerosis. It works by targeting specific receptors in your immune system to prevent harmful immune cells from entering your brain and spinal cord. Think of it as creating a protective barrier that keeps your immune system from mistakenly attacking your own nervous tissue.

This medication is relatively new compared to other MS treatments, having been approved by the FDA in 2019. It's specifically designed for people whose multiple sclerosis has progressed from the relapsing-remitting form to the secondary progressive stage. Your doctor will determine if siponimod is right for your particular situation based on your medical history and current symptoms.

What is Siponimod Used For?

Siponimod is primarily used to treat secondary progressive multiple sclerosis (SPMS). This form of MS typically develops after someone has had relapsing-remitting MS for several years. During the secondary progressive phase, symptoms tend to worsen gradually over time, even without clear relapses or flare-ups.

The medication helps slow down the progression of physical disability that often comes with SPMS. It can also reduce the number of relapses you experience, though this benefit may be less pronounced than in earlier stages of MS. Your neurologist might recommend siponimod if other treatments haven't been effective enough or if you're transitioning from relapsing-remitting to secondary progressive MS.

Sometimes doctors prescribe siponimod for certain cases of relapsing-remitting MS, particularly when the disease shows signs of progression. However, this use is less common and requires careful evaluation of your individual circumstances.

How Does Siponimod Work?

Siponimod works by blocking specific receptors called sphingosine 1-phosphate receptors on immune cells. When these receptors are blocked, certain white blood cells called lymphocytes become trapped in your lymph nodes and can't travel to your brain and spinal cord. This prevents them from causing the inflammation and damage that characterizes multiple sclerosis.

This medication is considered moderately strong compared to other MS treatments. It's more potent than some older medications like interferons, but it's not as aggressive as some of the newer high-efficacy treatments. The strength makes it effective for slowing disease progression while maintaining a manageable side effect profile for most people.

The drug also has some direct effects on cells in your nervous system, which may help protect nerve fibers from damage. This dual action of reducing inflammation and providing neuroprotection makes siponimod particularly useful for the progressive forms of MS.

How Should I Take Siponimod?

You should take siponimod exactly as your doctor prescribes, typically once daily with or without food. The medication comes in tablet form and should be swallowed whole with water. You don't need to take it with milk or any specific foods, but taking it at the same time each day helps maintain consistent levels in your body.

Your doctor will start you on a special titration pack that gradually increases your dose over several days. This starter pack helps your body adjust to the medication and reduces the risk of side effects. The typical starting schedule increases from 0.25 mg on day one to your target maintenance dose by day six.

Before starting siponimod, you'll need some important tests. Your doctor will check your heart rhythm with an EKG and may monitor your heart rate for several hours after your first dose. They'll also test your blood for certain genetic markers that affect how your body processes the medication. These precautions help ensure your safety throughout treatment.

If you eat before taking siponimod, choose light meals rather than heavy, fatty foods. While food doesn't significantly affect absorption, some people find that taking it with a small snack helps reduce stomach upset. Avoid grapefruit and grapefruit juice, as these can interfere with how your body processes the medication.

How Long Should I Take Siponimod For?

Siponimod is typically a long-term treatment that you'll continue indefinitely as long as it's helping your MS and you're tolerating it well. Most people with secondary progressive MS need ongoing treatment to slow disease progression, so stopping the medication usually isn't recommended unless problems arise.

Your doctor will monitor your response to the medication through regular check-ups and periodic MRI scans. These assessments help determine whether siponimod is effectively slowing your disease progression. If the medication stops working or if you develop concerning side effects, your doctor may discuss switching to a different treatment.

Some people may need to take breaks from siponimod for medical procedures or if they develop certain infections. Your doctor will guide you through any temporary stops and help you restart safely when appropriate. Never stop taking siponimod suddenly without medical supervision, as this can lead to a severe worsening of your MS symptoms.

What Are the Side Effects of Siponimod?

Like all medications, siponimod can cause side effects, though not everyone experiences them. Most side effects are mild to moderate and often improve as your body adjusts to the medication. Understanding what to expect can help you feel more prepared and know when to contact your healthcare team.

Here are the most common side effects you might experience:

• Headaches, which often improve after the first few weeks
• High blood pressure that your doctor will monitor regularly
• Abnormal liver function tests, usually without symptoms
• Dizziness or feeling lightheaded, especially when standing up
• Nausea or stomach discomfort, particularly in the first month
• Swelling in your legs, ankles, or feet
• Tremor or slight shaking, usually mild

These common side effects are generally manageable and often decrease over time. Your doctor will monitor you closely, especially during the first few months of treatment.

Some less common but more serious side effects require immediate medical attention. These include signs of serious infections like fever, chills, or persistent cough, since siponimod can lower your immune system's ability to fight infections. You should also watch for symptoms of liver problems such as yellowing of your skin or eyes, dark urine, or severe abdominal pain.

Rarely, siponimod can cause more severe complications. These might include serious heart rhythm problems, severe swelling throughout your body, or signs of a brain infection called PML (progressive multifocal leukoencephalopathy). While these serious side effects are uncommon, being aware of them helps you seek prompt medical care if needed.

Some people may experience mood changes or depression while taking siponimod. If you notice significant changes in your mood, sleep patterns, or thoughts, it's important to discuss these with your healthcare provider promptly.

Who Should Not Take Siponimod?

Siponimod isn't right for everyone, and certain medical conditions or circumstances make it unsafe to use. Your doctor will carefully review your medical history and current health status before prescribing this medication. Being honest about your health conditions helps ensure your safety.

You should not take siponimod if you have certain heart conditions. These include recent heart attack, unstable angina, severe heart failure, or certain types of irregular heart rhythms. The medication can affect your heart rate and rhythm, particularly when you first start taking it.

People with severe liver disease should avoid siponimod because the liver processes this medication. Your doctor will test your liver function before starting treatment and monitor it regularly while you're taking the drug. If you have active hepatitis or severe liver impairment, siponimod may not be safe for you.

Certain genetic factors also affect whether you can safely take siponimod. People with specific genetic variations (called CYP2C9*3/*3) process the medication very slowly, which can lead to dangerous levels in the blood. Your doctor will test for these genetic markers before prescribing siponimod.

You should also avoid siponimod if you're pregnant, planning to become pregnant, or breastfeeding. The medication can harm a developing baby and passes into breast milk. Women of childbearing age need to use effective contraception while taking siponimod and for at least 10 days after stopping it.

Active serious infections are another reason to avoid or delay starting siponimod. Since the medication suppresses your immune system, it can make existing infections worse or harder to treat. Your doctor will ensure any infections are properly treated before starting this medication.

Siponimod Brand Names

Siponimod is sold under the brand name Mayzent in the United States and many other countries. This is the primary brand name you'll see on your prescription bottle and medication packaging. Mayzent is manufactured by Novartis, a pharmaceutical company that developed this medication specifically for multiple sclerosis treatment.

Currently, there are no generic versions of siponimod available. This means Mayzent is the only form of siponimod you can get by prescription. Generic versions typically become available several years after a brand-name drug loses patent protection, but this hasn't happened yet for siponimod.

In some countries outside the United States, siponimod might be available under different brand names or may not be approved yet. If you're traveling or moving internationally, it's important to work with your healthcare provider to ensure continuity of your treatment.

Siponimod Alternatives

Several other medications can treat secondary progressive multiple sclerosis if siponimod isn't right for you. Your doctor will consider your specific situation, including your medical history, other health conditions, and how well you've responded to previous treatments when suggesting alternatives.

Ocrelizumab (Ocrevus) is another medication approved for secondary progressive MS. It's given as an intravenous infusion every six months and works differently than siponimod by targeting specific immune cells. Some people prefer the convenience of less frequent dosing, while others prefer taking a daily pill.

For people with relapsing-remitting MS who might be transitioning to secondary progressive, there are several other options. These include fingolimod (Gilenya), which works similarly to siponimod but has a longer track record, and natalizumab (Tysabri), which is highly effective but requires regular monitoring for a rare brain infection.

Older medications like interferon beta and glatiramer acetate are still options for some people, though they're generally less effective than newer treatments. Your doctor might consider these if you have specific medical conditions that make newer medications unsuitable.

The choice between alternatives depends on many factors including your age, other health conditions, previous treatment responses, and personal preferences about things like injection frequency and monitoring requirements.

Is Siponimod Better Than Fingolimod?

Both siponimod and fingolimod work similarly by affecting sphingosine 1-phosphate receptors, but they have some important differences. Siponimod is specifically approved for secondary progressive MS, while fingolimod is primarily used for relapsing-remitting MS. This makes direct comparisons somewhat difficult since they're often used for different stages of the disease.

Siponimod may have some advantages in terms of side effects. It's less likely to cause the eye problems (macular edema) that can occur with fingolimod, and it may have fewer effects on lung function. However, both medications require careful heart monitoring when you first start taking them.

The choice between these medications often comes down to your specific type of MS and your individual medical situation. If you have secondary progressive MS, siponimod is specifically designed for your condition. If you have relapsing-remitting MS, fingolimod might be more appropriate, though your doctor will consider all the factors.

Both medications are effective, and neither is universally "better" than the other. Your neurologist will help you understand which medication is most likely to benefit your particular situation while minimizing risks based on your overall health profile.